![]() |
|
RESÚMENES MAYO 2008 |
Schizophrenia-Psychotic Disorders & Antipsychotics
(Haga un click en la información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos
países de la región iberoamericana (algunos artículos requieren ir a la tabla
de contenidos del número actual de la revista)
3 - IQ tests as aids to diagnosis and
management in early schizophrenia
Phil
Harrison-Read
Advances
in Psychiatric Treatment (2008) 14: 235-240
3! - Birth weight of infants after
maternal exposure to typical and atypical antipsychotics: prospective
comparison study
James
J. Newham, Simon H. Thomas, Karine MacRitchie, Patricia R. McElhatton,
R. Hamish McAllister-Williams
The
British Journal of Psychiatry (2008) 192: 333-337
GRATIS 3 - Non-adherence to antipsychotic medication,
relapse and rehospitalisation in recent-onset schizophrenia
Gunnar
Morken, Jan H Widen
and Rolf W Grawe
3 - The possible involvement of metabotropic
glutamate receptors in schizophrenia
Amir Krivoy, Tsvi Fischel and Abraham Weizman
European Neuropsychopharmacology.
Volume 18, Issue 6, June 2008, Pages 395-405
3 -
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: Role of serotonin 5-HT1A receptors
Hiroko
Hagiwara, Yuko Fujita, Tamaki Ishima, Shinsui Kunitachi, Yukihiko Shirayama, Masaomi Iyo and Kenji Hashimoto
European Neuropsychopharmacology.
Volume 18, Issue 6, June 2008, Pages 448-454
5 - Sexual functioning
associated with quetiapine switch vs. risperidone continuation in outpatients
with schizophrenia or schizoaffective disorder: A randomized double-blind pilot
trial
Matthew J. Byerly, Paul A. Nakonezny and A. John Rush
Psychiatry Research. Volume 159, Issues 1-2, 30 May 2008, Pages 115-120
5< - Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction
in schizophrenia: A 12-week double-blind, placebo-controlled pilot study
Trino Baptista
, Euderruh
Uzcátegui, Nairy Rangel, Yamily El Fakih, Tatiana Galeazzi, Serge
Beaulieu and Enma Araujo de Baptista
Psychiatry Research. Volume 159, Issues 1-2, 30 May 2008, Pages 250-253
3 - Olanzapine and risperidone block
a high dose of methamphetamine-induced schizophrenia-like behavioral
abnormalities and accompanied apoptosis in the medial prefrontal cortex
Tomohiro
Abekawa,
Koki Ito, Shin Nakagawa, Yasuya Nakato and Tsukasa Koyama
Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 84-94
3! - An
increased risk of stroke among young schizophrenia patients
Herng-Ching Lin, Fei-Hsiu Hsiao, Stefani Pfeiffer, Yi-Ting Hwang and Hsin-Chien Lee
Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 234-241
3! - Use of medications to reduce cardiovascular risk
among individuals with psychotic disorders and Type 2
diabetes
Julie Kreyenbuhl, Deborah R. Medoff, Stephen L. Seliger and Lisa B. Dixon
Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 256-265
5 - Metabolic syndrome in first episode schizophrenia — A randomized double-blind controlled, short-term prospective
study
Sahoo Saddichha, Narayana Manjunatha, Shahul
Ameen and Sayeed
Akhtar
Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 266-272
4 -
Change in metabolic syndrome parameters with antipsychotic treatment in the
CATIE Schizophrenia Trial: Prospective data from phase 1
Jonathan M. Meyer, Vicki G. Davis, Donald C. Goff, Joseph P. McEvoy
, Henry A. Nasrallah, , Sonia M. Davis, Robert A. Rosenheck, Gail L. Daumit, John Hsiao, Marvin S. Swartz, T. Scott Stroupand Jeffrey A.
Lieberman
Schizophrenia Research. Volume 101, Issues 1-3,
April 2008, Pages 273-286
3! -
Early treatment-related changes in diabetes and cardiovascular disease risk
markers in first episode psychosis subjects
Karen
A. Graham, Hyunsoon Cho,
Kimberly A. Brownleyand Joyce B.
Harp
Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 287-294
3 - Typical and atypical antipsychotics differentially
affect long-term incidence rates of the metabolic syndrome in first-episode
patients with schizophrenia: A retrospective chart review
Marc De Hert, Vincent Schreurs, Kim Sweers, Dominique Van Eyck, Linda Hanssens, Sebastjan
Šinko, Martien
Wampers, Andre Scheen, Joseph Peuskens and Ruud
van Winkel
Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 295-303
3 - Antipsychotic treatment patterns and hospitalizations
among adults with schizophrenia